Elizabeth Pingpank | Associate Director, Corporate Communications |
Nick Leschly | CEO |
Philip Gregory | Chief Scientific Officer |
Dave Davidson | Chief Medical Officer |
Dr. Mohammed Asmal | VP, Clinical Development |
Salveen Richter | Goldman Sachs |
Chris Shibutani | Cowen |
Matthew Harrison | Morgan Stanley |
Matthew Luchini | BMO Capital Markets |
Michael Schmidt | Guggenheim |
Yanan Zhu | Wells Fargo Securities |
Gena Wang | Barclays |
Mark Breidenbach | Oppenheimer |
Vincent Chen | Bernstein |
Raju Prasad | William Blair |
Good day, ladies and gentlemen, and welcome to the bluebird bio Third Quarter Update Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference call may be recorded. I would now like to introduce your host for today’s conference, Ms.